SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010010
Filing Date
2019-11-05
Accepted
2019-11-05 17:30:43
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20190930x10q.htm   iXBRL 10-Q 1326186
2 EX-10.1 imgn-20190930ex101478ee7.htm EX-10.1 82235
3 EX-31.1 imgn-20190930ex3119becc9.htm EX-31.1 11574
4 EX-32 imgn-20190930xex32.htm EX-32 7829
  Complete submission text file 0001558370-19-010010.txt   6913980

Data Files

Seq Description Document Type Size
5 EX-101.SCH imgn-20190930.xsd EX-101.SCH 55486
6 EX-101.CAL imgn-20190930_cal.xml EX-101.CAL 41490
7 EX-101.DEF imgn-20190930_def.xml EX-101.DEF 230778
8 EX-101.LAB imgn-20190930_lab.xml EX-101.LAB 517357
9 EX-101.PRE imgn-20190930_pre.xml EX-101.PRE 402695
59 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20190930x10q_htm.xml XML 1245760
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 191194417
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences